What is the Human Medicines Regulations 2012 test?

The regulations define a medicinal product in two ways: by presentation, meaning it is described or offered as treating or preventing disease, and by function, meaning it acts pharmacologically, immunologically or metabolically in the body. Either limb can apply, so labelling something differently does not necessarily take it outside the definition.

Is it illegal to sell peptides in the UK?

Supplying or advertising an unlicensed medicinal product to the public is an offence under UK medicines law. Whether a given product falls within that depends on the substance and how it is presented. Enforcement is directed mainly at manufacture, supply and advertising rather than at a private individual, but that is a general pattern rather than a rule: possessing with intent to supply, passing product to someone else, and importing can each engage separate offences.

Is possession for personal use an offence?

It depends on the substance, and the answer is narrower than it sounds. UK medicines law is aimed principally at manufacture, supply and advertising, and possessing a product with intent to supply it to someone else is itself prohibited. Separately, some substances discussed in this field are controlled drugs, where a completely different test applies. None of this means a substance has been assessed, approved or judged safe. This is general information, not legal advice.

Do anti-doping rules follow the same lines as the law?

No. WADA anti-doping rules are a separate regime that applies to athletes in tested sport regardless of whether a substance is lawful. Many peptides sit on the prohibited list, and a positive test brings sanctions independently of anything the criminal or medicines law says.

What happens when peptides are imported from overseas?

Importing raises separate customs and Border Force issues on top of medicines law. Packages can be inspected, detained or destroyed, and importing an unlicensed medicinal product is treated differently from importing an ordinary consumer good. The overseas seller being lawful in its own country does not settle the UK position.

Are peptides legal in the UK? The regulatory picture, explained

There is no single answer, because peptide is a chemistry word rather than a legal category. UK law treats each substance according to what it is, how it is presented and what it does.

Resources - REGULATION

Are peptides legal in the UK? The regulatory picture, explained

There is no single answer, because peptide is a chemistry word rather than a legal category. UK law treats each substance according to what it is, how it is presented and what it does.

There is no single answer to whether peptides are legal in the UK, and anyone giving you one is oversimplifying. "Peptide" is a chemistry word - it describes a short chain of amino acids - and chemistry words are not legal categories. UK law does not regulate molecules by structural family. It asks what a specific substance is, how it is being presented, what it does in the body, and what is being done with it. Two peptides can therefore sit in completely different legal positions, and the same peptide can sit in different positions depending on who is supplying it and how.

The useful thing is not a yes or no answer but an understanding of the framework, because the framework is what determines the answer in any particular case. Three categories do most of the work: licensed medicines, unlicensed medicinal products, and substances sold as research chemicals. Those categories are not about chemistry at all. They are about assessment and authorisation.

What is a licensed medicine?

A licensed medicine has been assessed by the Medicines and Healthcare products Regulatory Agency and granted a marketing authorisation. That assessment covers manufacturing quality, safety, the balance of benefit against harm, and the conditions under which the product may be used. Some licensed medicines are prescription-only, meaning they may lawfully be supplied to a person only against a prescription from an appropriate prescriber. A licensed peptide medicine used through that route is entirely lawful, and the route runs through a prescriber and a pharmacy.

A small number of peptides are licensed prescription-only medicines in the UK. Others have never been through that process anywhere. The existence of a licensed peptide product does not confer any status on a chemically similar compound, on the same compound from a different source, or on the same compound supplied outside that route. Authorisation attaches to a specific product from a specific manufacturer, not to a molecule in the abstract.

What is an unlicensed medicinal product?

An unlicensed medicinal product is something that meets the legal definition of a medicinal product but holds no marketing authorisation. This is the category that catches most of what is being asked about, and the important point is that a product can land in it without the seller intending it or labelling it that way.

Under the Human Medicines Regulations 2012, a medicinal product is defined in two ways. The presentation limb covers anything presented as having properties for treating or preventing disease in human beings. The function limb covers anything that may be used in, or administered to, human beings with a view to restoring, correcting or modifying a physiological function by exerting a pharmacological, immunological or metabolic action. Either limb is enough on its own.

The function limb is why labels cannot settle the question. If a substance acts pharmacologically in the body and is capable of being used in people, calling it something else does not automatically remove it from the definition. This is the legal reason that "research use only" is not a safe harbour, which our separate article on that phrase covers in full. Presentation matters too, and it is assessed in the round: the claims made, the imagery, the packaging format, the surrounding copy and the audience being addressed all feed into whether something is being presented as a medicine.

Is supplying or advertising unlicensed products an offence?

Yes. Placing an unlicensed medicinal product on the UK market is an offence under UK medicines law, and advertising one is a separate offence - for a product with no marketing authorisation, the advertising prohibition is not limited to advertising aimed at the public. There is a further, distinct rule that prescription-only medicines may not be advertised to the public at all. There are narrow, defined exceptions in the regulations - for example the specials regime, which allows an unlicensed product to be supplied to meet the special clinical needs of an individual patient on the responsibility of a prescriber - but that regime is hedged with conditions: the order must be unsolicited, no advertisement for the product may be published, and the product must be made or imported by the holder of a specific manufacturer's licence. It is a clinical pathway, not a commercial one. Enforcement is a matter for the MHRA, and it falls on the person manufacturing, supplying or advertising.

What about possession for personal use?

UK medicines law is directed primarily at manufacture, supply and advertising rather than at simple personal possession, so an individual who holds a substance for their own use is generally in a different position from someone selling it. That distinction is real, and it is the source of the widespread claim that these substances are "legal to buy". It is worth being precise about what it does and does not mean.

It means the medicines regime is not principally aimed at private possession. It does not mean the substance has been assessed, approved, tested for safety, or judged suitable for anyone. It does not mean the supply chain that produced it was lawful. It does not mean there is no risk. And it does not apply universally: a peptide could separately fall under other legislation, and controlled drugs law and the Psychoactive Substances Act 2016 operate on entirely different tests, so the general position on possession under medicines law is not a blanket rule.

Do anti-doping rules follow the same lines?

No, and this trips people up regularly. The World Anti-Doping Agency prohibited list is a private regulatory regime that applies to athletes in tested sport through their sport's rules, and it operates entirely independently of the criminal and medicines law. A substance not being prohibited by criminal law is irrelevant to whether it is prohibited in sport. Many peptides, including growth hormone secretagogues and various peptide hormones, appear on the prohibited list, and several categories are prohibited at all times rather than only in competition.

Under anti-doping rules, athletes are generally held strictly responsible for what is found in their sample, regardless of intent, and contamination of a product is not an automatic defence. Anyone in tested sport should treat the prohibited list and their own governing body's guidance as the operative rulebook, separate from anything in this article.

What does importing add?

Importing from an overseas seller raises a separate layer of issues on top of medicines law. Goods entering the UK are subject to customs controls, and Border Force can inspect, detain or destroy packages. Importing an unlicensed medicinal product is not treated the same as importing an ordinary consumer good, and personal importation of medicines is subject to its own restrictions. The fact that a seller operates lawfully in its own country does not resolve the UK position, because the relevant question is what the law here says about the product arriving here. Some substances discussed in this field are also controlled drugs, where importation is governed by misuse-of-drugs law rather than by medicines law, and the rules are stricter.

"Peptide" is a chemistry word, so there is no single legal answer for the whole class.
A licensed medicine has been assessed by the MHRA and may be prescription-only.
The Human Medicines Regulations 2012 define a medicinal product by presentation and by function - either limb is enough.
Supplying or advertising an unlicensed medicinal product to the public is an offence.
Possession for personal use is generally treated differently from supply, but that is not approval and not a safety judgement.
WADA anti-doping rules are a separate regime that applies to tested athletes regardless of legality.
Importing brings customs and Border Force issues that sit on top of medicines law.

Put together, the picture is less confusing than it first appears. UK law does not ask what family a molecule belongs to. It asks whether a particular product has been assessed and authorised, how it is being presented, what it does in the body, and what is being done with it - and the answers differ compound by compound and situation by situation. That is why the honest answer to the headline question is that it depends, and why anyone offering a blanket yes or no is telling you something the law does not actually say.

This is general information about how the UK regulatory framework works. It is not legal advice, it is not medical advice, and it does not address any individual situation. Law and regulatory guidance change, and how the framework applies depends entirely on the specific facts. If you have a specific question, take proper legal or medical advice from a qualified professional.

Frequently asked

Are peptides legal in the UK?: There is no single answer, because peptide is a chemistry word and not a legal category. UK law looks at each individual substance and at how it is supplied. Some peptides are licensed prescription-only medicines, some are unlicensed medicinal products, and the rules differ accordingly.
What is the Human Medicines Regulations 2012 test?: The regulations define a medicinal product in two ways: by presentation, meaning it is described or offered as treating or preventing disease, and by function, meaning it acts pharmacologically, immunologically or metabolically in the body. Either limb can apply, so labelling something differently does not necessarily take it outside the definition.
Is it illegal to sell peptides in the UK?: Supplying or advertising an unlicensed medicinal product to the public is an offence under UK medicines law. Whether a given product falls within that depends on the substance and how it is presented. Enforcement is directed mainly at manufacture, supply and advertising rather than at a private individual, but that is a general pattern rather than a rule: possessing with intent to supply, passing product to someone else, and importing can each engage separate offences.
Is possession for personal use an offence?: It depends on the substance, and the answer is narrower than it sounds. UK medicines law is aimed principally at manufacture, supply and advertising, and possessing a product with intent to supply it to someone else is itself prohibited. Separately, some substances discussed in this field are controlled drugs, where a completely different test applies. None of this means a substance has been assessed, approved or judged safe. This is general information, not legal advice.
Do anti-doping rules follow the same lines as the law?: No. WADA anti-doping rules are a separate regime that applies to athletes in tested sport regardless of whether a substance is lawful. Many peptides sit on the prohibited list, and a positive test brings sanctions independently of anything the criminal or medicines law says.
What happens when peptides are imported from overseas?: Importing raises separate customs and Border Force issues on top of medicines law. Packages can be inspected, detained or destroyed, and importing an unlicensed medicinal product is treated differently from importing an ordinary consumer good. The overseas seller being lawful in its own country does not settle the UK position.